Upgrade to SI Premium - Free Trial

NeOnc posts wider Q2 loss, plans NEO100 trial data release Aug. 12

August 10, 2026 9:00 AM
NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) reported a net loss of $14.2 million, or $(0.58) per diluted share, for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA